Relación entre kinesiofobia, capacidad al ejercicio y funcionalidad en pacientes con Parkinson y congelación de la marcha en ``On

Relación entre kinesiofobia, capacidad al ejercicio y funcionalidad en pacientes con Parkinson y congelación de la marcha en ``On

Contenido principal del artículo

Javier Martín Núñez

Resumen

Enfermedad de Parkinson (EP) es la segunda enfermedad neurodegenerativa más común en el mundo y la primera en Europa, presentando una prevalencia cada vez mayor debido a su correlación con la edad. La congelación de la marcha es un trastorno motor que provoca un bloqueo principalmente de miembros inferiores, generando la incapacidad de dar el paso. Además la congelación de la marcha es uno de los trastornos motores más incapacitantes de la EP, sobre todo en las fases más avanzadas de la enfermedad y que además se relaciona con otras complicaciones, como son el riesgo de caídas, limitación de actividades e incluso calidad de vida; esto a su vez induce a una disminución del movimiento y actividad física de los pacientes con EP y congelación de la marcha. A pesar de que estudios previos muestran la relación entre kinesiofobia, capacidad al ejercicio y funcionalidad en pacientes con EP, no hay evidencias sobre esta relación en aquellos que presentan congelación de la marcha en ``On´´.

Citas

Balestrino, R., & Schapira, A. H. V. (2020). Parkinson disease. European Journal of Neurology, 27(1), 27–42. https://doi.org/10.1111/ene.14108

Bloem, B. R., Hausdorff, J. M., Visser, J. E., & Giladi, N. (2004). Falls and freezing of Gait in Parkinson’s disease: A review of two interconnected, episodic phenomena. Movement

Disorders, 19(8), 871–884. https://doi.org/10.1002/mds.20115

Bryant, M. S., Hou, J. G., Collins, R. L., & Protas, E. J. (2016). Contribution of Axial Motor Impairment to Physical Inactivity in Parkinson Disease. American Journal of Physical Medicine and Rehabilitation, 95(5), 348–354. https://doi.org/10.1097/PHM.0000000000000384

Cetin, S. Y., Basakci Calik, B., Ayan, A., & Cavlak, U. (2019). Validity and reliability of the unsupported upper-limb exercise test in individuals with rheumatoid arthritis. International Journal of Rheumatic Diseases, 22(11), 2025–2030. https://doi.org/10.1111/1756-185X.13720

Darden, L. (2007). Mechanisms and models. The Cambridge Companion to the Philosophy of Biology, 39, 139–159. https://doi.org/10.1017/CCOL9780521851282.008

Franchignoni, F., Martignoni, E., Ferriero, G., & Pasetti, C. (2005). Balance and fear of falling in Parkinson’s disease. Parkinsonism and Related Disorders, 11(7), 427–433. https://doi.org/10.1016/j.parkreldis.2005.05.005

Giladi, N., McDermott, M. P., Fahn, S., Przedborski, S., Jankovic, J., Stern, M., & Tanner, C. (2001). Freezing of gait in PD: Prospective assessment in the DATATOP cohort. Neurology, 56(12), 1712–1721. https://doi.org/10.1212/WNL.56.12.1712

Granger, C. V., Markello, S. J., Graham, J. E., Deutsch, A., Reistetter, T. A., & Ottenbacher, K. J. (2010). The uniform data system for medical rehabilitation: Report of patients with traumatic brain injury discharged from rehabilitation programs in 2000-2007. American Journal of Physical Medicine and Rehabilitation, 89(4), 265–278. https://doi.org/10.1097/PHM.0b013e3181d3eb20

Holroyd, S., Currie, L. J., & Wooten, G. F. (2008). Validity, sensitivity and specificity of the mentation, behavior and mood subscale of the UPDRS. Neurological Research, 30(5), 493–496. https://doi.org/10.1179/016164107X251772

Hurtig-Wennlf, A., Hagstrmer, M., & Olsson, L. A. (2010). The International Physical Activity Questionnaire modified for the elderly: Aspects of validity and feasibility. Public Health Nutrition, 13(11), 1847–1854. https://doi.org/10.1017/S1368980010000157

Janaudis-Ferreira, T., Beauchamp, M. K., Goldstein, R. S., & Brooks, D. (2012). How should we measure arm exercise capacity in patients with COPD? A systematic review. Chest, 141(1), 111–120. https://doi.org/10.1378/chest.11-0475

Jankovic, J. (2008). Parkinson’s disease: Clinical features and diagnosis. Journal of Neurology, Neurosurgery and Psychiatry, 79(4), 368–376. https://doi.org/10.1136/jnnp.2007.131045

Lee, A., & Gilbert, R. M. (2016). Epidemiology of Parkinson Disease. Neurologic Clinics, 34(4), 955–965. https://doi.org/10.1016/j.ncl.2016.06.012

Leentjens, A. F. G., Dujardin, K., Marsh, L., Richard, I. H., Starkstein, S. E., & Martinez-Martin, P. (2011). Anxiety rating scales in Parkinson’s disease: A validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale. Movement Disorders, 26(3), 407–415. https://doi.org/10.1002/mds.23184

Lima, V. P., Velloso, M., Pessoa, B. P., Almeida, F. D., Ribeiro-Samora, G. A., & Janaudis-Ferreira, T. (2020). Reference values for the Unsupported Upper Limb Exercise test in healthy adults in Brazil. Jornal Brasileiro de Pneumologia : Publicacao Oficial Da Sociedade Brasileira de Pneumologia e Tisilogia, 46(1), e20180267. https://doi.org/10.1590/1806-3713/e20180267

Maritz, R., Tennant, A., Fellinghauer, C., Stucki, G., & Prodinger, B. (2019). The functional independence measure 18-item version can be reported as a unidimensional interval-scaled metric: Internal construct validity revisited. Journal of Rehabilitation Medicine, 51(3), 193–200. https://doi.org/10.2340/16501977-2525

Monticone, M., Ferrante, S., Ambrosini, E., Rocca, B., Secci, C., & Foti, C. (2015). Development of the Tampa Scale of Kinesiophobia for Parkinson’s disease: Confirmatory factor analysis, reliability, validity and sensitivity to change. International Journal of Rehabilitation Research, 38(2), 113–120. https://doi.org/10.1097/MRR.0000000000000095

Nakamura, K., Nagasawa, Y., Sawaki, S., Yokokawa, Y., & Ohira, M. (2016). Effect of different seat heights during an incremental Sit-to-stand exercise test on peak oxygen uptake in young, healthy women. Journal of Sports Science and Medicine, 15(3), 410–416.

Nakamura, K., Nagasawa, Y., Sawaki, S., Yokokawa, Y., Ohira, M., & Sato, Y. (2019). An incremental sit-to-stand exercise for evaluating physical capacity in older patients with type 2 diabetes. Tohoku Journal of Experimental Medicine, 249(4), 241–248. https://doi.org/10.1620/tjem.249.241

Nakamura, K., Ohira, M., Yokokawa, Y., & Nagasawa, Y. (2015). Validity and reproducibility of an incremental sit-to-stand exercise test for evaluating anaerobic threshold in young, healthy individuals. Journal of Sports Science and Medicine, 14(4), 708–715.

Nieuwboer, A., Dom, R., De Weerdt, W., Desloovere, K., Fieuws, S., & Broens-Kaucsik, E. (2001). Abnormalities of the spatiotemporal characteristics of Gait at the onset of freezing in Parkinson’s disease. Movement Disorders, 16(6), 1066–1075. https://doi.org/10.1002/mds.1206

Nonnekes, J., Timmer, M. H. M., de Vries, N. M., Rascol, O., Helmich, R. C., & Bloem, B. R. (2016). Unmasking levodopa resistance in Parkinson’s disease. Movement Disorders, 31(11), 1602–1609. https://doi.org/10.1002/mds.26712

Pavese, N., Rimoldi, O., Gerhard, A., Brooks, D. J., & Piccini, P. (2004). Cardiovascular effects of methamphetamine in Parkinson’s disease patients. Movement Disorders, 19(3), 298–303. https://doi.org/10.1002/mds.10651

Politis, M., Wu, K., Molloy, S., Bain, P. G., Chaudhuri, K. R., & Piccini, P. (2010). Parkinson’s disease symptoms: The patient’s perspective. Movement Disorders, 25(11), 1646–1651. https://doi.org/10.1002/mds.23135

Pollak, N., Rheault, W., & Stoecker, J. L. (1996). Reliability and validity of the FIM for persons aged 80 years and above from a multilevel continuing care retirement community. Archives of Physical Medicine and Rehabilitation, 77(10), 1056–1061. https://doi.org/10.1016/S0003-9993(96)90068-4

Ridgel, A. L., Walter, B. L., Tatsuoka, C., Walter, E. M., Colón-Zimmermann, K., Welter, E., & Sajatovic, M. (2016). Enhanced Exercise Therapy in Parkinson’s disease: A comparative effectiveness trial. Journal of Science and Medicine in Sport, 19(1), 12–17. https://doi.org/10.1016/j.jsams.2015.01.005

Saqlain, M., Alam, M., Rönnegård, L., & Westin, J. (2020). Investigating Stochastic Differential Equations Modelling for Levodopa Infusion in Patients with Parkinson’s Disease. European Journal of Drug Metabolism and Pharmacokinetics, 45(1), 41–49. https://doi.org/10.1007/s13318-019-00580-w

Shulman, L. M. (2010). Understanding disability in Parkinson’s disease. Movement Disorders, 25(SUPPL. 1), 131–135. https://doi.org/10.1002/mds.22789

Snijders, A. H., Takakusaki, K., Debu, B., Lozano, A. M., Krishna, V., Fasano, A., Aziz, T. Z., Papa, S. M., Factor, S. A., & Hallett, M. (2016). Physiology of freezing of gait. Annals of Neurology, 80(5), 644–659. https://doi.org/10.1002/ana.24778

Stacy, M. (2011). Nonmotor symptoms in Parkinson’s disease. International Journal of Neuroscience, 121(SUPPL. 2), 9–17. https://doi.org/10.3109/00207454.2011.620196

Sveinbjornsdottir, S. (2016). The clinical symptoms of Parkinson’s disease. Journal of Neurochemistry, 139, 318–324. https://doi.org/10.1111/jnc.13691

Takahashi, T., Jenkins, S. C., Strauss, G. R., Watson, C. P., & Lake, F. R. (2003). A New Unsupported Upper Limb Exercise Test for Patients with Chronic Obstructive Pulmonary Disease. Journal of Cardiopulmonary Rehabilitation, 23(6), 430–437. https://doi.org/10.1097/00008483-200311000-00007

Vlaeyen, J. W. S., & Linton, S. J. (2000). Fear-avoidance and its consequences in chronic musculoskeletal pain: A state of the art. Pain, 85(3), 317–332. https://doi.org/10.1016/S0304-3959(99)00242-0